LC
TXG icon

Lindbrook Capital’s 10x Genomics TXG Stock Holding History

Lindbrook Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$5.03K Buy
576
+214
+59% +$2.7K ﹤0.01% 1948
2024
Q4 		$5.2K Sell
362
-515
-59% -$8.13K ﹤0.01% 1970
2024
Q3 		$19.8K Buy
877
+549
+167% +$11.3K ﹤0.01% 1305
2024
Q2 		$6.38K Buy
328
+259
+375% +$6.78K ﹤0.01% 1874
2024
Q1 		$2.59K Buy
69
+1
+1% +$44 ﹤0.01% 2151
2023
Q4 		$3.81K Sell
68
-134
-66% -$5.83K ﹤0.01% 2025
2023
Q3 		$8.33K Sell
202
-12
-6% -$624 ﹤0.01% 1505
2023
Q2 		$11.9K Buy
214
+12
+6% +$649 ﹤0.01% 1357
2023
Q1 		$11.3K Buy
202
+17
+9% +$794 ﹤0.01% 1373
2022
Q4 		$6.74K Buy
185
+177
+2,213% +$5.79K ﹤0.01% 1647
2022
Q3 		$0 Sell
8
-3
-27% -$114 ﹤0.01% 2911
2022
Q2 		$0 Sell
11
-24
-69% -$1.25K ﹤0.01% 2777
2022
Q1 		$3K Sell
35
-40
-53% -$3.5K ﹤0.01% 1886
2021
Q4 		$11K Buy
75
+55
+275% +$8.42K ﹤0.01% 1243
2021
Q3 		$3K Buy
+20
New +$3.43K ﹤0.01% 1450

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lindbrook Capital's TXG Position: Q1 2025 in Review

Lindbrook Capital increased its 10x Genomics (TXG) stake by 59% in Q1 2025, buying an estimated $2.7K and bringing the position to 576 shares worth $5.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Lindbrook Capital first reported a position in TXG in Q3 2021 and has held it in 15 quarters since. The position peaked at $19.8K in Q3 2024. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Lindbrook Capital held 576 shares of 10x Genomics worth $5.03K as of Q1 2025.
  • Lindbrook Capital bought 214 10x Genomics shares in Q1 2025, an estimated $2.7K.
  • 10x Genomics made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1948 holding.
  • Lindbrook Capital first reported a position in 10x Genomics in Q3 2021 and has held it in 15 quarters since.
  • Lindbrook Capital's 10x Genomics position peaked at $19.8K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.